Evaluation of Lung Ultrasonography Findings in Newborns With Respiratory Syncytial Virus Bronchiolitis
Launched by KIRIKKALE UNIVERSITY · Jan 11, 2024
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Respiratory Syncytial Virus (RSV) is a type of negative-strand RNA viruses. It is a seasonal, highly contagious pathogen belonging to the family Pneumoviridae (genus orthopneumovirus). RSV is a common cause of respiratory disease throughout life but is associated with significant morbidity and mortality, especially in infants and older adults.
RSV infections account for approximately 60% to 80% of bronchiolitis in infancy and 40% of pediatric pneumonias.
Bronchiolitis is an acute lower respiratory tract infection that affects children under one or two years of age and is the most common c...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All newborns hospitalized with viral lower respiratory tract findings in the neonatal intensive care unit of Kırıkkale University Faculty of Medicine Hospital
- • Patients with study approval
- • Patients who underwent lung ultrasonography were included in the study.
- Exclusion Criteria:
- • Newborns who do not lie down due to viral lower respiratory tract infection
- • Patients without study consent
- • Patients for whom lung ultrasonography could not be performed
About Kırıkkale University
Kırıkkale University is a distinguished academic institution based in Turkey, recognized for its commitment to advancing medical research and education. The university actively engages in clinical trials aimed at enhancing healthcare outcomes and contributing to the scientific community. With a focus on innovation and collaboration, Kırıkkale University leverages its multidisciplinary expertise to conduct rigorous clinical studies that address pressing health challenges. Its research initiatives are guided by ethical standards and a dedication to improving patient care through evidence-based findings.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kırıkkale, , Turkey
Patients applied
Trial Officials
Sevde Nur nu Vural, Asistant Dr
Study Chair
KIRIKKALE UNİVERSİTY FACULTY OF MEDİCİNE
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported